Intralesional 5 Fluorouracil For Basal Cell Carcinoma: A Case Review. Journal of Pharmaceutical Negative Results, [S. l.], p. 4579–4583, 2022. DOI: 10.47750/pnr.2022.13.S09.567. Disponível em: https://mail.pnrjournal.com/index.php/home/article/view/4412.. Acesso em: 15 oct. 2025.